Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

Unconventional bioprinting modalities for advanced tissue biofabrication

Derman ID., Kim MH., Sarikaya MD., Yilmaz YO., Aliftiras EG., Stepanyants V.

Narrative Review on Face & Skin, published in Biomaterials (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Biomaterials (2026)
Reported sample size
—
Source database
Europe PMC
PMID
40976137
PMCID
PMC12810354
DOI
10.1016/j.biomaterials.2025.123704
Citations
4

Abstract (original English)

Bioprinting has been widely used to fabricate three-dimensional constructs for various applications. However, conventional bioprinting modalities face challenges such as low resolution, poor repeatability, limited speed, and scalability constraints. To overcome these limitations, unconventional bioprinting modalities have been actively developed, utilizing electric fields, acoustic waves, magnetic forces, light, smart materials, and microfluidics to advance bioprinted tissues. This Review explores various unconventional bioprinting modalities, which significantly improve upon conventional counterparts to create complex, scalable heterogenous tissue constructs. In addition, emerging bioprinting methods, utilizing the principles of conventional or unconventional bioprinting modalities with new concepts integrated, such as embedded bioprinting, cryobioprinting, microgravity bioprinting and 4D bioprinting, were discussed. Key applications include functional tissue engineering, disease modeling, and organoid development, with future directions focusing on artificial intelligence-driven bioprinting, multimodal biofabrication, and intraoperative bioprinting to improve scalability and clinical translation. By integrating interdisciplinary innovations, unconventional bioprinting offers new opportunities to advance tissue biofabrication technologies.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansTissue EngineeringTissue ScaffoldsBioprintingPrinting, Three-Dimensional

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research